Aspira Womens Health Q2 2024 GAAP EPS $(0.28) Beats $(0.30) Estimate, Sales $2.423M Miss $2.600M Estimate
Portfolio Pulse from Benzinga Newsdesk
Aspira Womens Health (NASDAQ:AWH) reported Q2 2024 GAAP EPS of $(0.28), beating the estimate of $(0.30). However, sales of $2.423M missed the $2.600M estimate, marking a 2.73% decrease from the same period last year.
August 12, 2024 | 8:08 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aspira Womens Health reported a Q2 2024 GAAP EPS of $(0.28), beating the estimate of $(0.30). However, sales of $2.423M missed the $2.600M estimate, showing a 2.73% decrease from the same period last year.
The EPS beat is a positive sign, but the miss on sales and the year-over-year decline in revenue could offset the positive sentiment. This mixed result is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100